Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Application of Oncolytic Virus in Recurrent Glioblastoma

NCT07145047 is registered in ClinicalTrials.gov with Mianyang Central Hospital as lead sponsor.

NCT NCT07145047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Application of Oncolytic Virus in Recurrent Glioblastoma
Lead sponsor
Mianyang Central Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 2, 2023
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma (gbm)